Further investigation of the identified CpG site in the gene body of CDKN2A in combination with genetic alterations for a large cohort of these sarcoma subtypes may identify a new diagnostic option for stratification of high-grade pleomorphic sarcomas. Here, CDKN2A is linked to sarcoma.